Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Differences in asthma clinical outcomes according to initial severity.

Vicente Plaza1, Joan Serra-Batlles, Agustí Comella

  • 1Department de Pneumologia, Hospital de la Santa Creu i Sant Pau de Barcelona, Barcelona, Spain. vplaza@hsp.santpau.es

The Journal of Asthma : Official Journal of the Association for the Care of Asthma
|June 21, 2005
PubMed
Summary

Asthma prognosis significantly differs based on initial severity. Mild asthma patients showed better clinical outcomes, quality of life, and lung function compared to moderate and severe cases over three years.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Evidence Update for Tezepelumab to Treat Severe Uncontrolled Asthma, Corticosteroid-dependent Asthma, Chronic Rhinosinusitis With Nasal Polyposis, and Chronic Obstructive Pulmonary Disease. 2nd Barcelona Respiratory Network report.

Open respiratory archives·2026
Same author

Advancing in precision asthma management: The Treat-to-Target by Treatable Traits (T4) framework.

Respiratory medicine·2026
Same author

Evaluation of the SEPAR-ALAT Asthma Exacerbation Severity Classification.

Archivos de bronconeumologia·2026
Same author

Expert review and recommendations on the diagnosis and therapeutic management of eosinophilic granulomatosis with polyangiitis.

Frontiers in immunology·2026
Same author

Artificial Intelligence in Asthma: From Diagnosis to Management.

Journal of investigational allergology & clinical immunology·2026
Same author

Real-World Effectiveness and Safety of Single Inhaler Triple Therapy with Beclometasone/ Formoterol/ Glycopyrronium in Moderate to Severe Asthma: TriMaximize Study.

Journal of asthma and allergy·2026

Area of Science:

  • Pulmonology
  • Clinical Medicine
  • Respiratory Health

Background:

  • Limited data exists on asthma morbidity outcomes relative to initial disease severity.
  • Understanding prognostic differences is crucial for tailored patient management.

Purpose of the Study:

  • To investigate variations in asthma morbidity, quality of life (QOL), and lung function based on initial asthma severity.
  • To compare outcomes over a three-year follow-up period.

Main Methods:

  • A three-year prospective cohort study involving 235 asthma patients stratified by initial severity (mild, moderate, severe).
  • Data collection included asthma morbidity, clinical data, spirometry (measuring forced expiratory volume in 1 second - FEV1), and the St. George's Respiratory Questionnaire (SGRQ) for QOL assessment.

Related Experiment Videos

Main Results:

  • Overall, significant improvements in asthma morbidity, pulmonary function (FEV1), and QOL (SGRQ scores) were observed after three years.
  • Patients with mild asthma demonstrated statistically significant improvements in primary care visit frequency and SGRQ scores compared to moderate and severe groups.
  • While all groups showed some improvement, the magnitude of change in FEV1 and SGRQ scores was most favorable in the mild asthma cohort.

Conclusions:

  • Asthma prognosis is significantly influenced by the initial severity of the disease.
  • Mild asthma patients generally experience better clinical, QOL, and pulmonary function outcomes compared to those with moderate and severe asthma.
  • These findings underscore the importance of considering baseline severity for predicting long-term asthma management success.